Endo Health Solutions Inc. (ENDP) - Financial and Strategic SWOT Analysis Review

Document Sample
Endo Health Solutions Inc. (ENDP) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					              Endo Health Solutions Inc. (ENDP) - Financial and Strategic SWOT
                                      Analysis Review
        Reference Code: GDPH5159FSA                                                                                           Publication Date: MAR 2013

          1400 Atwater Drive                                 Phone              +1 484 2160000                  Revenue          3,027.4 (million USD)
          Malvern, PA                                        Fax                                                Net Profit       -740.34 (million USD)
          19355                                              Website            www.endo.com                    Employees        4,629
                                                                                                                                 Pharmaceuticals           &
          United States                                      Exchange           ENDP [NASDAQ]                   Industry
                                                                                                                                 Healthcare

       Company Overview
       Endo Health Solutions Inc., (Endo) formerly called Endo Pharmaceuticals Holding Inc., is a specialty healthcare solutions
       company that focuses on innovation, development and commercialization of various pharmaceutical drugs and healthcare
       devices with a special focus on pain management and urology segments. The company operates its business through four
       business segment, namely, Endo Pharmaceuticals, Qualitest, AMS and HealthTronics. The company operates through its
       subsidiaries some of which are Endo Pharmaceuticals Inc., American Medical Systems Holdings, Inc., Qualitest pharmaceuticals
       and HealthTronics, Inc. among other subsidiaries.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Endo Health Solutions Inc., SWOT Analysis
         David P. Holveck                    Chief Executive Officer                  Strengths                              Weaknesses
         John J. Delucca                     Director
                                                                                      Diversified Product and Service Revenue Concentration:
         Michael Hyatt                       Director                                 Offerings                       Branded Pharmaceuticals
         Joseph C. Scodari                   Director
                                                                                      Sturdy Research and                    Limited Customer Base
         William F. Spengler                 Director                                 Development Activities
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData
                                                                                      Opportunities                          Threats
       Share Data
         Endo Health Solutions Inc.                                                   Inorganic Growth Strategies            Stringent Government
                                                                                                                             Regulations
        Share Price (USD) as on 22-Mar-                                30.85          Emerging Markets
        2013                                                                                                                 Dependence on Third Party
        EPS (USD)                                                       -6.40                                                Manufacturers
        Market Cap (million USD)                                       3,429
        Enterprise Value (million USD)                                 6,113         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Shares Outstanding (million)                                     111
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Feb 28, 2013         Endo Reports Revenue Of $3 Billion In 2012
                                                                                      Feb 25, 2013         Endo Health Solutions Names Rajiv De Silva
                                                                                                           As CEO
                                                                                      Dec 12, 2012         Endo's CEO David Holveck To Retire
                                                                                      Nov 05, 2012         Endo Reports Revenue Of $750.5m In Q3
                                                                                                           2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData



       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Endo Health Solutions Inc. (ENDP) - Financial and Strategic SWOT                                                                Reference Code: GDPH5159FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Endo Health Solutions Inc. - Key Facts .............................................................................................................................................. 5
       Endo Health Solutions Inc. - Key Employees ..................................................................................................................................... 6
       Endo Health Solutions Inc. - Key Employee Biographies ................................................................................................................... 7
       Endo Health Solutions Inc. - Major Products and Services ................................................................................................................ 9
       Endo Health Solutions Inc. - Pharmaceutical Pipeline Products Data .............................................................................................. 11
          Endo Health Solutions Inc., Pipeline Products by Therapy Area .................................................................................................. 11
          Endo Health Solutions Inc., Pipeline Products by Development Phase ........................................................................................ 12
       Endo Health Solutions Inc. - History ................................................................................................................................................. 13
       Endo Health Solutions Inc. - Company Statement ........................................................................................................................... 17
       Endo Health Solutions Inc. - Locations And Subsidiaries ................................................................................................................. 20
          Head Office ................................................................................................................................................................................... 20
          Other Locations & Subsidiaries ..................................................................................................................................................... 20
       Section 2 – Company Analysis ......................................................................................................................................................... 21
       Endo Health Solutions Inc. - Business Description........................................................................................................................... 21
       Endo Health Solutions Inc. - Corporate Strategy .............................................................................................................................. 23
       Endo Health Solutions Inc. - SWOT Analysis ................................................................................................................................... 24
          SWOT Analysis - Overview........................................................................................................................................................... 24
          Endo Health Solutions Inc. - Strengths ......................................................................................................................................... 24
             Strength - Diversified Product and Service Offerings ................................................................................................................ 24
             Strength - Sturdy Research and Development Activities ........................................................................................................... 24
             Strength - Intellectual Property .................................................................................................................................................. 24
          Endo Health Solutions Inc. - Weaknesses .................................................................................................................................... 25
             Weakness - Revenue Concentration: Branded Pharmaceuticals .............................................................................................. 25
             Weakness - Limited Customer Base ......................................................................................................................................... 25
             Weakness - Product Recalls ..................................................................................................................................................... 25
          Endo Health Solutions Inc. - Opportunities ................................................................................................................................... 25
             Opportunity - Inorganic Growth Strategies ................................................................................................................................ 25
             Opportunity - Emerging Markets ............................................................................................................................................... 25
             Opportunity - New Product Approvals and Launches ................................................................................................................ 26
          Endo Health Solutions Inc. - Threats ............................................................................................................................................ 26
             Threat - Stringent Government Regulations .............................................................................................................................. 26
             Threat - Dependence on Third Party Manufacturers ................................................................................................................. 26
             Threat - Competitive Pressures ................................................................................................................................................. 26
       Endo Health Solutions Inc. - Key Competitors.................................................................................................................................. 27
       Section 3 – Company Financial Ratios ............................................................................................................................................. 28
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 28
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 28
       Performance Chart ........................................................................................................................................................................... 30
       Financial Performance...................................................................................................................................................................... 30
       Financial Ratios - Interim Ratios....................................................................................................................................................... 31
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 32


Endo Health Solutions Inc. (ENDP) - Financial and Strategic SWOT                                                                                                 Reference Code: GDPH5159FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 33
          Endo Health Solutions Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................................. 33
          Endo Health Solutions Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ................................................. 34
       Endo Health Solutions Inc., Recent Deals Summary ....................................................................................................................... 35
       Section 5 – Company’s Recent Developments ................................................................................................................................ 36
          Endo Health Solutions Inc., Recent Developments ...................................................................................................................... 36
             Feb 28, 2013: Endo Reports Revenue Of $3 Billion In 2012 ..................................................................................................... 36
             Feb 25, 2013: Endo Health Solutions Names Rajiv De Silva As CEO ...................................................................................... 38
             Dec 12, 2012: Endo's CEO David Holveck To Retire ................................................................................................................ 38
             Nov 05, 2012: Endo Reports Revenue Of $750.5m In Q3 2012 ............................................................................................... 39
           
				
DOCUMENT INFO
Description: Endo Health Solutions Inc., (Endo) formerly called Endo Pharmaceuticals Holding Inc., is a specialty healthcare solutions company that focuses on innovation, development and commercialization of various pharmaceutical drugs and healthcare devices with a special focus on pain management and urology segments. The company operates its business through four business segment, namely, Endo Pharmaceuticals, Qualitest, AMS and HealthTronics. The company operates through its subsidiaries some of which are Endo Pharmaceuticals Inc., American Medical Systems Holdings, Inc., Qualitest pharmaceuticals and HealthTronics, Inc. among other subsidiaries.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.